Cognitive impairment in cancer pain patients receiving opioids: A pilot study

Cancer Nursing

Volumn 31, Issue 1, 2008, Pages 49-57

  Kurita, Geana Paula ^a,b   De Mattos Pimenta, Cibele Andrucioli ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Depto ENC   (Brazil)

Author keywords

Attention; Cancer; Cognition; Cognitive disorders; Memory; Neuropsychological tests; Opioids; Pain; Palliative care; Treatment outcome

Indexed keywords

AMITRIPTYLINE; CHLORPROMAZINE; CODEINE; FENTANYL; METHADONE; MORPHINE; OPIATE DERIVATIVE; OXYCODONE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CANCER PAIN; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PAIN ASSESSMENT; PATIENT ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RECALL; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; WECHSLER INTELLIGENCE SCALE;

ADULT; AGED; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT;

EID: 38049069926     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NCC.0000305673.06211.cd     Document Type: Article

References (41)

1. Gazzaniga MS, Ivry RB, Mangun GR. Cognitive Neuroscience: The Biology of the Mind. 2nd ed. New York, NY: WW Norton & Co; 2002.
2. Lawlor PG. The panorama of opioid-related cognitive dysfunction in patients with cancer. Cancer. 2002;94(6):1836-1853.
3. Bruera E, Pereira J. Recent developments in palliative cancer care. Acta Oncol. 1998;37(7/8):749-757.
4. Daeninck PJ, Bruera E. Opioid use in cancer pain: is a more liberal approach enhancing toxicity? Acta Anaesthesiol Scand. 1999;43:924-938.
5. Pita G. Disturbances in recent memory and behavioral changes caused by the treatment with intraventricular morphine administration (IVM) in severe cancer pain. Hum Psychopharmacol Clin Exp. 1998;13:315-323.
6. Sjøgren P, Banning A. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain. 1989;39:5-11.
7. Clemons M, Regnard C, Appleton T. Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev. 1996;22:451-468.
8. Sjøgren P, Olsen AK, Thomsen AB, Dalberg J. Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain. 2000;86:237-245.
9. Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol. 1995;3(4):432-466.
10. Kress HG, Kraft B. Opioid medication and driving ability. Eur J Pain. 2005;9:141-144.
11. Sjøgren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19(2):100-108.
12. Chapman SL, Byas-Smith MG, Reed BA. Effects of intermediate and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain. 2002;18:S83-S90.
13. Twycross RG. Opioids. In: Wall PD, Melzack R, eds. Textbook of Pain. 4th ed. Toronto, ON: Churchill Livingstone; 1999:1187-1214.
14. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
15. Loring DW. INS Dictionary of Neuropsychology. New York, NY: Oxford University Press; 1999.
16. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York, NY: Oxford University Press; 1998.
17. Lezak M, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York, NY: Oxford University Press; 2004.
18. Wang CC, Kosinski CJ, Schwartzberg JG, Shanklin AV. Physician's Guide to Assessing and Counseling Older Drivers. Washington, DC: National Highway Traffic Safety Administration; 2003.
19. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
20. Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugestões para o uso do mini-exame do estado mental no Brasil. Arq Neuropsiquiatr. 2003;61(3-B):777-781.
21. Wechsler D. Wechsler Adult Intelligence Scale - Revised. New York, NY: Psychological Corp; 1981.
22. Sternberg RJ. Psicologia Cognitiva. Porto Alegre, Brazil: Artes Médicas Sul; 2000.
23. Nitrini R, Caramelli P, Herrera E Jr, et al. Performance of illiterate and literate nondemented elderly subjects in two tests of long-term memory. J Int Neuropsychol Soc. 2004;10:634-638.
24. Brucki SMD, Malheiros SMF, Okamoto IH, Bertolucci PHF. Dados normativos para o uso do teste de fluência verbal categoria animais em nosso meio. Arq Neuropsiquiatr. 1997;55:56-61.
25. Burns A, Lawlor B, Craig S. Assessment Scales in Old Age Psychiatry. London, UK: Martin Dunitz; 1999.
26. Beck AT. Terapia Cognitiva da Depressão [Apêndice: materiais]. Rio de Janeiro: Zahar; 1982:385-387.
27. Gorenstein L, Andrade L. Validation of a Portuguese version of the beck depression inventory and the state-trait anxiety inventory in Brazilian subjects. Braz J Med Biol Res. 1996;29:453-457.
28. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences. 2nd ed. New York, NY: McGraw-Hill; 1988.
29. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Oxford, UK: Blackwell Science; 1994.
30. Hendler N, Cimini C, Ma T, Long D. A comparison of cognitive impairment due to benzodiazepines and to narcotics. Am J Psychiatry. 1980;137(7):828-830.
31. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347(8995):143-147.
32. Galski T, Williams B, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage. 2000;19(3):200-208.
33. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59(7):1015-1021.
34. Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage. 2003;25(1):38-47.
35. Haythorthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage. 1998;15(3):185-194.
36. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage. 2003;26(4):913-921.
37. Menefee LA, Frank ED, Crerand C, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med. 2004;5(1):42.
38. Schuler M, Njoo N, Hestermann M, Oster P, Hauer K. Acute and chronic pain in geriatrics: clinical characteristics of pain and influence of cognition. Pain Med. 2004;5(3):253-262.
39. Tassain V, Attal N, Fletcher D, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain. 2003;104:389-400.
40. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995;346:667-670.
41. Lorenz J, Beck H, Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain. 1997;73:369-375.